Testimony on Possible Switch of Orlistat (Xenical) to OTC Status

Testimony of Sidney M. Wolfe M.D. and Elizabeth Barbehenn, Ph.D.,
Public Citizen’s Health Research Group

Before the FDA Non-Prescription and Endocrine and Metabolic Drug Advisory Committees
Hearing on Possible Switch of Orlistat (Xenical) to OTC Status

View the presentation slides in PDF format